Financials
Financial year 2025
RAES PHARMACEUTICAL LOGISTICS from Gent, company number BE0525781372, closed financial year 2025 with a result of € 813,666 after tax. For that financial year RAES PHARMACEUTICAL LOGISTICS recorded a gross margin of € 3.8 million and equity of € 1.4 million. Compared with financial year 2024, the result moved from € 234,967 to € 813,666. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 15, 2026.
€ 1.4 million
▲ 140% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 813,666
▲ 246% vs 2024
Profit after tax over the fiscal year.
€ 126,117
▲ € 112,786 vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € -1.6 million.
People and assets in 2025
43.4
▲ 33 vs 2024
Average over the fiscal year, from the social balance sheet.
€ 2.6 million
▲ 26% vs 2024
€ 59,600 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 428,486
▼ 3% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 417,169
▼ 40% vs 2024
€ 159,620 is repaid this year. At this pace the long-term loan is gone in ≈ 3 years.
€ 540,411
▼ 11% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 476,361
▲ 16% vs 2024
Taxes, VAT and social contributions still to pay.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 1,672,454 | € 1,822,563 | € 2,599,289 | € 3,783,718 | ▲ 46% |
| Profit after taxes | € 2,483 | € -249,628 | € 234,967 | € 813,666 | ▲ 246% |
| Equity | € 593,829 | € 344,200 | € 579,167 | € 1,392,833 | ▲ 140% |
| Total debts | € 2,294,197 | € 2,392,626 | € 2,047,815 | € 1,433,941 | ▼ 30% |
| Cash | € 4,226 | € 22,190 | € 13,330 | € 126,117 | ▲ € 112,786 |
| Retained profit | € -2,386,171 | € -2,635,800 | € -2,400,833 | € -1,587,167 | ▲ € 813,666 |
| Bank debt | € 905,889 | € 798,525 | € 691,827 | € 417,169 | ▼ 40% |
| Balance sheet total | € 2,888,025 | € 2,736,827 | € 2,626,982 | € 2,826,775 | ▲ 8% |
| Employees (FTE) | 25.4 | 29.3 | 10.4 | 43.4 | ▲ 33 |
By gross margin, RAES PHARMACEUTICAL LOGISTICS ranks 1st of 10 companies with main activity “Goederenvervoer over de weg” in Gent that publish figures (fiscal year 2025).
Key figures of RAES PHARMACEUTICAL LOGISTICS, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
Ask about RAES PHARMACEUTICAL LOGISTICS the way you would ask their accountant.
Answers from the filed annual accounts, the Belgian Official Gazette and the CBE register.
Connect ChatGPT or Claude for free- ChatGPT
- Claude
Free account, no payment card. Key figures unlimited, the annual accounts and deeds of 10 companies a month. Need more? Get in touch, we are looking for our first pilot users.
What happened to RAES PHARMACEUTICAL LOGISTICS?
What happened at RAES PHARMACEUTICAL LOGISTICS in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- Frank Van Bastelaere stepped down as director. NBB
- Nele Raes stepped down as director. NBB
- Dirk Raes stepped down as director. NBB
- New annual accounts for financial year 2025: profit of € 813,666 (▲ 246% vs 2024). Source: NBB ↗
- Frank Van Bastelaere became a director. NBB
- Nele Raes became a director. NBB
- Dirk Raes became a director. NBB
- New establishment in Gent. KBO
In short
From € 2,483 profit in 2022 to € 813,666 profit in 2025.
Paid € 1,199 in corporate taxes since 2022.
Best year ever: 2025, with € 813,666 profit.
On average € 87,200 of value added per employee in 2025.
Management
The stake of "NEST" comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
RAES PHARMACEUTICAL LOGISTICSThe shares are held by "NEST" (80.6%).
Establishments
Establishment units
Physical locations of this company
Moerstraat 48/50
9031 Gent
Moerstraat 58 box C
9031 Gent
Active since 1 January 2021
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Similar companies in Gent
Same main activity (Goederenvervoer over de weg), 12 active companies in Gent, largest first.
€ 2.4 million gross margin · 2025
€ 1.1 million gross margin · 2026
€ 1 million gross margin · 2025
€ 404,994 gross margin · 2024
€ 401,651 gross margin · 2026
€ 366,751 gross margin · 2025
Shareholders according to the Official Gazette deeds
Who contributed at incorporation and at capital increases, with the deed as source. Later share transfers are not published in the Gazette.
Capital increase
Source: Deed ↗- NEST(intekenaar) 70.5%
- DIRK RAES-ANDREA MONSIEUR(intekenaar) 7.6%
- FRANK VAN BASTELAERE(intekenaar) 3.3%
- NELE RAES(intekenaar) 1.1%
Incorporation
Source: Deed ↗- NEST(oprichter) 96%
- RAES Dirk Clement Leontine(oprichter) 2%
- VAN BASTELAERE Frank Philippe Olivier Maurice Robert(oprichter) 1%
- RAES Neie Geertrui(oprichter) 1%
Details
- Company number
- 0525.781.372
- VAT number
- BE 0525.781.372
- Registered office
- Moerstraat 48/50, 9031 Gent
- Names & denominations
- RAES PHARMACEUTICAL LOGISTICS · RPL
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 4 April 2013
- Peppol
- Active · Active since 26 Nov 2025
- Activities · NACE
Goederenvervoer over de weg
Groothandel in farmaceutische en medische artikelen